The heterogeneity of psoriatic arthritis (PsA) suggests a high number of undiagnosed manifestations. Guidance is provided by the CASPAR classification criteria. Therapy concepts should be multimodal – supported by a broad spectrum of drugs, which is systematized here.
Dieser Inhalt ist nur für Benutzer der Gruppe: zugänglich
Jetzt beitreten
Jetzt beitreten
Already a member? Log in here
